|

Gemcitabine 1000 mg Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 2

Top Sponsors

  • National Cancer Institute, Naples1
  • Loma Linda University1

Indications

  • Cancer2
  • Adenocarcinoma of the Pancreas1
  • Resectable Pancreatic Cancer1
  • Pancreas Adenocarcinoma1

Other1 trial

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
Phase 2

Loma Linda, California1 trial

Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer

Loma Linda University Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.